AM-928
EpCAM‑positive solid tumors (colorectal, nasopharyngeal, esophageal)
Phase 1Active
Key Facts
Indication
EpCAM‑positive solid tumors (colorectal, nasopharyngeal, esophageal)
Phase
Phase 1
Status
Active
Company
About AcadeMab Biomedical
Taiwan biotech integrating antibody and mRNA‑LNP technologies to target oncology and infectious disease unmet needs.
View full company profile